Literature DB >> 3804380

Evidence for a novel HLA antigen found on human extravillous trophoblast and a choriocarcinoma cell line.

S A Ellis, I L Sargent, C W Redman, A J McMichael.   

Abstract

We describe the characterization of a novel HLA Class I molecule, which we have isolated from chorionic cytotrophoblast cell membranes, and from a trophoblast-derived choriocarcinoma cell line, BeWo; classical HLA Class I antigens are not expressed on these cells. This antigen is an electrophoretically non-polymorphic glycoprotein of approximately 40,000 molecular weight, which is found in association with beta 2 microglobulin, and which is detected by monoclonal antibodies recognizing monomorphic determinants of HLA Class I. Elucidation of the nature and origin of this molecule may provide valuable information regarding the immune barrier that exists between mother and fetus.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3804380      PMCID: PMC1453327     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  18 in total

1.  A monoclonal antibody that recognizes an antigenic determinant shared by HLA A2 and B17.

Authors:  A J McMichael; P Parham; N Rust; F Brodsky
Journal:  Hum Immunol       Date:  1980-09       Impact factor: 2.850

2.  Class 1 major histocompatibility complex antigens on human extra-villous trophoblast.

Authors:  C W Redman; A J McMichael; G M Stirrat; C A Sunderland; A Ting
Journal:  Immunology       Date:  1984-07       Impact factor: 7.397

Review 3.  Genes of the major histocompatibility complex.

Authors:  L Hood; M Steinmetz; R Goodenow
Journal:  Cell       Date:  1982-04       Impact factor: 41.582

4.  Characterization of a monoclonal anti-beta 2-microglobulin antibody and its use in the genetic and biochemical analysis of major histocompatibility antigens.

Authors:  F M Brodsky; W F Bodmer; P Parham
Journal:  Eur J Immunol       Date:  1979-07       Impact factor: 5.532

5.  A human thymocyte antigen defined by a hybrid myeloma monoclonal antibody.

Authors:  A J McMichael; J R Pilch; G Galfré; D Y Mason; J W Fabre; C Milstein
Journal:  Eur J Immunol       Date:  1979-03       Impact factor: 5.532

6.  Absence of the cancer-associated factor with a molecular weight of 60,000 from the plasma of patients with a spectrum of nonneoplastic conditions.

Authors:  D E Schumm; M E Hanausek-Walaszek; Z Walaszek; T E Webb
Journal:  Cancer Res       Date:  1984-01       Impact factor: 12.701

7.  Recognition of HLA-B27 and related antigen by a monoclonal antibody.

Authors:  S A Ellis; C Taylor; A McMichael
Journal:  Hum Immunol       Date:  1982-08       Impact factor: 2.850

8.  Definition of four HLA-A2 subtypes by CML typing and biochemical analysis.

Authors:  J J van der Poel; H Mölders; A Thompson; H L Ploegh
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

9.  A monoclonal antibody recognizing a human thymus leukemia-like antigen associated with beta 2-microglobulin.

Authors:  R W Knowles; W F Bodmer
Journal:  Eur J Immunol       Date:  1982-08       Impact factor: 5.532

10.  Biochemical characterization of a second family of human Ia molecules, HLA-DS, equivalent to murine I-A subregion molecules.

Authors:  S M Goyert; J E Shively; J Silver
Journal:  J Exp Med       Date:  1982-08-01       Impact factor: 14.307

View more
  55 in total

Review 1.  The importance of HLA-G expression in embryos, trophoblast cells, and embryonic stem cells.

Authors:  Roberta Rizzo; Martine Vercammen; Hilde van de Velde; Peter A Horn; Vera Rebmann
Journal:  Cell Mol Life Sci       Date:  2010-11-16       Impact factor: 9.261

2.  Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor.

Authors:  M Ponte; C Cantoni; R Biassoni; A Tradori-Cappai; G Bentivoglio; C Vitale; S Bertone; A Moretta; L Moretta; M C Mingari
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

Review 3.  Disturbances in placental immunology: ready for therapeutic interventions?

Authors:  Sinuhe Hahn; Anurag Kumar Gupta; Carolyn Troeger; Corinne Rusterholz; Wolfgang Holzgreve
Journal:  Springer Semin Immunopathol       Date:  2006-04-26

4.  A commentary on gestational programming and functions of HLA-G in pregnancy.

Authors:  J S Hunt; P J Morales; J L Pace; A T Fazleabas; D K Langat
Journal:  Placenta       Date:  2007-03-09       Impact factor: 3.481

5.  Expression and analysis of the rat placental class I cDNA clone encoding the Pa antigen.

Authors:  A Radojcic; H W Kunz; T J Gill
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

6.  Peripheral blood natural killer cells and mild thyroid abnormalities in women with reproductive failure.

Authors:  P Triggianese; C Perricone; P Conigliaro; M S Chimenti; R Perricone; C De Carolis
Journal:  Int J Immunopathol Pharmacol       Date:  2015-12-10       Impact factor: 3.219

Review 7.  Regulation of fetal allograft survival by a hormone-controlled Th1- and Th2-type cytokines.

Authors:  M P Piccinni; S Romagnani
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

8.  Membrane-bound and water-soluble nonclassical class I MHC antigens on rat placenta.

Authors:  V J Fowler; S R Dalchau; J W Fabre
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

9.  Ankylosing spondylitis without B27: no evidence for gene conversion.

Authors:  C T Pease; S A Ellis; A J McMichael; D A Brewerton
Journal:  Ann Rheum Dis       Date:  1988-12       Impact factor: 19.103

Review 10.  Maternal and fetal T cells in term pregnancy and preterm labor.

Authors:  Derek Miller; Meyer Gershater; Rebecca Slutsky; Roberto Romero; Nardhy Gomez-Lopez
Journal:  Cell Mol Immunol       Date:  2020-05-28       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.